Noam Schneck1, Jeffrey M Miller2, Christine Delorenzo3, Toshiaki Kikuchi4, M Elizabeth Sublette2, Maria A Oquendo2, J John Mann2, Ramin V Parsey5. 1. Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University, New York, NY, United States. Electronic address: schneck@nyspi.columbia.edu. 2. Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University, New York, NY, United States. 3. Department of Psychiatry, Columbia University, New York, NY, United States; Department of Psychiatry and Behavioral Science, Stony Brook University School of Medicine, United States. 4. Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, United States; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. 5. Department of Psychiatry and Behavioral Science, Stony Brook University School of Medicine, United States.
Abstract
BACKGROUND: The lower-expressing (S') alleles of the serotonin transporter (5-HTT) gene promoter polymorphism (5-HTTLPR) are linked to mood and anxiety related psychopathology. However, the specific neural mechanism through which these alleles may influence emotional and cognitive processing remains unknown. We examined the relationship between both 5-HTTLPR genotype and in vivo 5-HTT binding quantified via PET with amygdala reactivity to emotionally negative stimuli. We hypothesized that 5-HTT binding in both raphe nuclei (RN) and amygdala would be inversely correlated with amygdala reactivity, and that number of S' alleles would correlate positively with amygdala reactivity. METHODS: In medication-free patients with current major depressive disorder (MDD; N=21), we determined 5-HTTLPR genotype, employed functional magnetic resonance imaging (fMRI) to examine amygdala responses to negative emotional stimuli, and used positron emission tomography with [(11)C]DASB to examine 5-HTT binding. RESULTS: [(11)C]DASB binding in RN and amygdala was inversely correlated with amygdala response to negative stimuli. 5-HTTLPR S' alleles were not associated with amygdala response to negative emotional stimuli. LIMITATIONS: Primary limitations are small sample size and lack of control group. CONCLUSIONS: Consistent with findings in healthy volunteers, 5-HTT binding is associated with amygdala reactivity to emotional stimuli in MDD. 5-HTT binding may be a stronger predictor of emotional processing in MDD as compared with 5-HTTLPR genotype.
BACKGROUND: The lower-expressing (S') alleles of the serotonin transporter (5-HTT) gene promoter polymorphism (5-HTTLPR) are linked to mood and anxiety related psychopathology. However, the specific neural mechanism through which these alleles may influence emotional and cognitive processing remains unknown. We examined the relationship between both 5-HTTLPR genotype and in vivo 5-HTT binding quantified via PET with amygdala reactivity to emotionally negative stimuli. We hypothesized that 5-HTT binding in both raphe nuclei (RN) and amygdala would be inversely correlated with amygdala reactivity, and that number of S' alleles would correlate positively with amygdala reactivity. METHODS: In medication-free patients with current major depressive disorder (MDD; N=21), we determined 5-HTTLPR genotype, employed functional magnetic resonance imaging (fMRI) to examine amygdala responses to negative emotional stimuli, and used positron emission tomography with [(11)C]DASB to examine 5-HTT binding. RESULTS: [(11)C]DASB binding in RN and amygdala was inversely correlated with amygdala response to negative stimuli. 5-HTTLPR S' alleles were not associated with amygdala response to negative emotional stimuli. LIMITATIONS: Primary limitations are small sample size and lack of control group. CONCLUSIONS: Consistent with findings in healthy volunteers, 5-HTT binding is associated with amygdala reactivity to emotional stimuli in MDD. 5-HTT binding may be a stronger predictor of emotional processing in MDD as compared with 5-HTTLPR genotype.
Authors: Chih-Liang Chin; Robert A Carr; Daniel A Llano; Olivier Barret; Hongyu Xu; Jeffrey Batis; Andrei O Koren; John P Seibyl; Kennan C Marsh; Gilles Tamagnan; Michael W Decker; Mark Day; Gerard B Fox Journal: J Pharmacol Exp Ther Date: 2010-12-20 Impact factor: 4.030
Authors: P M Fisher; C C Meltzer; S K Ziolko; J C Price; E L Moses-Kolko; S L Berga; A R Hariri Journal: Nat Neurosci Date: 2006-10-01 Impact factor: 24.884
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman Journal: Am J Hum Genet Date: 2006-03-28 Impact factor: 11.025
Authors: Xianzhang Hu; Gabor Oroszi; Jeffrey Chun; Tom L Smith; David Goldman; Marc A Schuckit Journal: Alcohol Clin Exp Res Date: 2005-01 Impact factor: 3.455
Authors: Maria A Oquendo; Ramin S Hastings; Yung-Yu Huang; Norman Simpson; R Todd Ogden; Xian-Zhang Hu; David Goldman; Victoria Arango; Ronald L Van Heertum; J John Mann; Ramin V Parsey Journal: Arch Gen Psychiatry Date: 2007-02
Authors: Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger Journal: Science Date: 2002-07-19 Impact factor: 47.728
Authors: Elisabeth A H von dem Hagen; Luca Passamonti; Sarah Nutland; Jennifer Sambrook; Andrew J Calder Journal: Neuropsychologia Date: 2010-12-15 Impact factor: 3.139
Authors: Sergi G Costafreda; Peter McCann; Pascal Saker; James H Cole; Sarah Cohen-Woods; Anne E Farmer; Katherine J Aitchison; Peter McGuffin; Cynthia H Y Fu Journal: J Affect Disord Date: 2013-05-02 Impact factor: 4.839
Authors: Manesh Gopaldas; Francesca Zanderigo; Serena Zhan; R Todd Ogden; Jeffrey M Miller; Harry Rubin-Falcone; Thomas B Cooper; Maria A Oquendo; Gregory Sullivan; J John Mann; M Elizabeth Sublette Journal: J Affect Disord Date: 2019-07-05 Impact factor: 4.839